Your browser doesn't support javascript.
loading
Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review.
Shah, Yash B; Shaver, Amy L; Beiriger, Jacob; Mehta, Sagar; Nikita, Nikita; Kelly, William Kevin; Freedland, Stephen J; Lu-Yao, Grace.
Afiliação
  • Shah YB; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Shaver AL; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Beiriger J; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Mehta S; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Nikita N; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Kelly WK; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Freedland SJ; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Lu-Yao G; Section of Urology, Durham VA Medical Center, Durham, NC 27705, USA.
Cancers (Basel) ; 14(15)2022 Aug 03.
Article em En | MEDLINE | ID: mdl-35954437
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article